Log in to save to my catalogue

Overexpressed PKMYTI promotes tumor progression and associates with poor survival in esophageal squa...

Overexpressed PKMYTI promotes tumor progression and associates with poor survival in esophageal squa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A600162314

Overexpressed PKMYTI promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma

About this item

Full title

Overexpressed PKMYTI promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma

Publisher

Dove Medical Press Limited

Journal title

Cancer management and research, 2019-08, p.7813

Language

English

Formats

Publication information

Publisher

Dove Medical Press Limited

More information

Scope and Contents

Contents

Background: Esophageal squamous cell carcinoma (ESCC) is one of the most common malignant tumors worldwide and the 5-year overall survival rate remains poor. Protein kinase, membrane associated tyrosine/threonine (PKMYT1) is overexpressed in several cancers and participate in tumor progression. However, the mechanism of PKMYT1 in ESCC is unclear. P...

Alternative Titles

Full title

Overexpressed PKMYTI promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A600162314

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A600162314

Other Identifiers

ISSN

1179-1322

E-ISSN

1179-1322

DOI

10.2147/CMAR.S214243

How to access this item